Target intelligence / Profile preview

Pseudogene similar to part of SMT3 suppressor of mif two 3 (yeast)

Molecular classification
Other (pseudogene)
01

Overview

This genomic locus is a **pseudogene** with no known protein-coding function, annotated as similar to part of SMT3 suppressor of mif two 3 (yeast). SMT3 suppressor of mif two 3 is a yeast gene related to the human SUMO (Small Ubiquitin-like Modifier) gene family. However, ENSG00000235190 itself does not encode a functional SUMO protein, nor does it participate in sumoylation or related cellular processes. Key context and supporting details: - The annotation as a "pseudogene similar to part of SMT3 suppressor of mif two 3" means it derives from sequence homology to a segment of a yeast gene (SMT3), but lacks protein-coding and functional elements. - There are multiple functional SUMO family members (such as SUMO2, SUMO3) in humans, which are involved in post-translational modification, but this pseudogene has no documented role and is not referenced as a target in biomedical literature. - GeneCards, HUGO Gene Nomenclature Committee, and related databases classify ENSG00000235190 specifically as a pseudogene—the most authoritative designation in genomic research. - It is not a member of any canonical therapeutic target families. Human protein-coding SUMO genes have aliases and defined molecular roles, which do not extend to this pseudogene. In summary, **ENSG00000235190 is not a drug target and is instead classified as a non-functional pseudogene with a nomenclature reflecting homology to the yeast SMT3 gene. All other fields related to therapeutic targeting, biological function, and druggability are not applicable**.

Other names
SMT3 suppressor of mif two 3-related pseudogene

Beyond the preview

Go deeper on Pseudogene similar to part of SMT3 suppressor of mif two 3 (yeast).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of SMT3 suppressor of mif two 3 (yeast).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call